These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7744127)

  • 1. Special considerations in the use of NSAIDs in the elderly.
    Todesco S
    Eur J Rheumatol Inflamm; 1994; 14(1):7-13. PubMed ID: 7744127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of etodolac in aged patients affected by degenerative joint disease (osteoarthritis) in its active phase.
    Todesco S; Del Ross T; Marigliano V; Ariani A
    Int J Clin Pharmacol Res; 1994; 14(1):11-26. PubMed ID: 7927957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsteroidal anti-inflammatory drug use in the elderly: issues of compliance and safety.
    Kirchner JT
    J Am Osteopath Assoc; 1994 Apr; 94(4):300-4. PubMed ID: 8026998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An updated safety profile of etodolac in several thousand patients.
    Schattenkirchner M
    Eur J Rheumatol Inflamm; 1990; 10(1):56-65. PubMed ID: 2146132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal anti-inflammatory drugs in the elderly.
    Buffum M; Buffum JC
    Pain Manag Nurs; 2000 Jun; 1(2):40-50. PubMed ID: 11706458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a nonsteroidal antiinflammatory drug on synovial fluid in osteoarthritis.
    Schumacher HR; Meng Z; Sieck M; Zonay L; Clayburne G; Baker JF; Park J; Baker DG
    J Rheumatol; 1996 Oct; 23(10):1774-7. PubMed ID: 8895157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use and safety profile of non-steroidal antiinflammatory drugs among Turkish patients with osteoarthritis.
    Yilmaz H; Gürel S; Ozdemir O
    Turk J Gastroenterol; 2005 Sep; 16(3):138-42. PubMed ID: 16245223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta.
    Hogan DB; Campbell NR; Crutcher R; Jennett P; MacLeod N
    CMAJ; 1994 Aug; 151(3):315-22. PubMed ID: 8039085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety profile of etodolac in the elderly population.
    Bacon PA
    Eur J Rheumatol Inflamm; 1994; 14(1):19-22. PubMed ID: 7744124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.
    Russell RI
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S14-8. PubMed ID: 10379464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people.
    Fosbøl EL; Gislason GH; Jacobsen S; Abildstrom SZ; Hansen ML; Schramm TK; Folke F; Sørensen R; Rasmussen JN; Køber L; Madsen M; Torp-Pedersen C
    Pharmacoepidemiol Drug Saf; 2008 Aug; 17(8):822-33. PubMed ID: 18383428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results from a patient survey to assess gastrointestinal burden of non-steroidal anti-inflammatory drug therapy contrasted with a review of data from EVA to determine satisfaction with rofecoxib.
    Steinfeld S; Bjørke PA
    Rheumatology (Oxford); 2002 Apr; 41 Supp 1():23-7; discussion 35-42. PubMed ID: 12173277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
    Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA
    Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk/benefit evaluation of NSAIDs in postoperative pain therapy.
    Nuutinen LS
    Acta Anaesthesiol Belg; 1996; 47(3):129-33. PubMed ID: 8959198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study.
    Sebaldt RJ; Petrie A; Goldsmith CH; Marentette MA
    Am J Manag Care; 2004 Nov; 10(11 Pt 1):742-50. PubMed ID: 15623264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualizing the risk/benefit ratio of NSAIDs in older patients.
    Sager DS; Bennett RM
    Geriatrics; 1992 Aug; 47(8):24-31. PubMed ID: 1634123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The multisystem adverse effects of NSAID therapy.
    James DS
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S1-7. PubMed ID: 10643174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of nonsteroidal anti-inflammatory drugs on the use of gastroprotective medication in people with arthritis.
    Lapane KL; Spooner JJ; Pettitt D
    Am J Manag Care; 2001 Apr; 7(4):402-8. PubMed ID: 11310194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbid conditions in the AMICA study patients: effects on the quality of life and drug prescriptions by general practitioners and specialists.
    Caporali R; Cimmino MA; Sarzi-Puttini P; Scarpa R; Parazzini F; Zaninelli A; Ciocci A; Montecucco C
    Semin Arthritis Rheum; 2005 Aug; 35(1 Suppl 1):31-7. PubMed ID: 16084231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.